Viewing Study NCT05130866


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2025-12-27 @ 12:43 AM
Study NCT ID: NCT05130866
Status: TERMINATED
Last Update Posted: 2025-10-07
First Post: 2021-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
Sponsor: Recursion Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module